These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28843002)

  • 1. HCV avidity as a tool for detection of recent HCV infection: Sensitivity depends on HCV genotype.
    Shepherd SJ; McDonald SA; Palmateer NE; Gunson RN; Aitken C; Dore GJ; Goldberg DJ; Applegate TL; Lloyd AR; Hajarizadeh B; Grebely J; Hutchinson SJ
    J Med Virol; 2018 Jan; 90(1):120-130. PubMed ID: 28843002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots.
    Eshetu A; Hauser A; An der Heiden M; Schmidt D; Meixenberger K; Ross S; Obermeier M; Ehret R; Bock CT; Bartmeyer B; Bremer V; Bannert N
    J Immunol Methods; 2020 Apr; 479():112744. PubMed ID: 31958450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatitis C avidity test for determining recent and past infections in both plasma and dried blood spots.
    Shepherd SJ; Kean J; Hutchinson SJ; Cameron SO; Goldberg DJ; Carman WF; Gunson RN; Aitken C
    J Clin Virol; 2013 May; 57(1):29-35. PubMed ID: 23369886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection.
    Patel EU; Cox AL; Mehta SH; Boon D; Mullis CE; Astemborski J; Osburn WO; Quinn J; Redd AD; Kirk GD; Thomas DL; Quinn TC; Laeyendecker O
    J Infect Dis; 2016 Aug; 214(3):344-52. PubMed ID: 26768250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection.
    Kanno A; Kazuyama Y
    J Med Virol; 2002 Oct; 68(2):229-33. PubMed ID: 12210412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
    J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index.
    Coppola N; Pisapia R; Tonziello G; Masiello A; Martini S; Pisaturo M; Messina V; Sagnelli C; Macera M; Signoriello G; Sagnelli E
    J Clin Virol; 2009 Nov; 46(3):222-9. PubMed ID: 19758839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.
    Gaudy-Graffin C; Lesage G; Kousignian I; Laperche S; Girault A; Dubois F; Goudeau A; Barin F
    J Clin Microbiol; 2010 Sep; 48(9):3281-7. PubMed ID: 20610669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody.
    Ward KN; Dhaliwal W; Ashworth KL; Clutterbuck EJ; Teo CG
    J Med Virol; 1994 Aug; 43(4):367-72. PubMed ID: 7525865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index.
    Klimashevskaya S; Obriadina A; Ulanova T; Bochkova G; Burkov A; Araujo A; Stramer SL; Tobler LH; Busch MP; Fields HA
    J Clin Microbiol; 2007 Oct; 45(10):3400-3. PubMed ID: 17715377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of low-avidity IgG antibodies in the diagnosis of primary acute infection by hepatitis C virus].
    León P; López JA; de Ory F; Elola C; Echevarría JM
    Enferm Infecc Microbiol Clin; 1997 Jan; 15(1):14-8. PubMed ID: 9147501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots.
    Brandão CP; Marques BL; Marques VA; Villela-Nogueira CA; Do Ó KM; de Paula MT; Lewis-Ximenez LL; Lampe E; Sá Ferreira JA; Villar LM
    J Clin Virol; 2013 Jun; 57(2):98-102. PubMed ID: 23518440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.
    Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G
    J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of antibody avidity and immunoglobulin M testing in acute HCV infection.
    Sagnelli E; Tonziello G; Pisaturo M; Sagnelli C; Coppola N
    Antivir Ther; 2012; 17(7 Pt B):1453-8. PubMed ID: 23322703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.
    Tuke PW; Grant PR; Waite J; Kitchen AD; Eglin RP; Tedder RS
    Transfusion; 2008 Apr; 48(4):594-600. PubMed ID: 18194388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Orlent H; Desombere I; Hansen B; Van Vlierberghe H; Haagmans B; De Knegt RJ; Schalm SW; Leroux-Roels G; Janssen HL;
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1443-8. PubMed ID: 21389795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and clinical performance of the Hologic Aptima HCV Quant Dx Assay for the quantification of HCV RNA in plasma samples.
    Schønning K; Pedersen MS; Johansen K; Landt B; Nielsen LG; Weis N; Westh H
    J Virol Methods; 2017 Oct; 248():159-165. PubMed ID: 28732692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HCV IgG avidity index in acute hepatitis C.
    Coppola N; Pisapia R; Marrocco C; Martini S; Vatiero LM; Messina V; Tonziello G; Sagnelli C; Filippini P; Piccinino F; Sagnelli E
    J Clin Virol; 2007 Oct; 40(2):110-5. PubMed ID: 17720621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.